Entre Plus
Payments companies reported to CMS as associated with Entre Plus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Entre Plus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Entre Plus
These are the largest totals companies reported as associated with Entre Plus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Antonios Gasparis | Huntington, NY | Vascular Surgery | $270,752.22 |
| Ron Karni | Houston, TX | Otolaryngology | $53,816.30 |
| Vinay Satwah | Greenbelt, MD | Interventional Cardiology | $46,076.45 |
| John Davis | Gilbert, AZ | Surgery | $45,720.09 |
| Thomas Odonnell | Boston, MA | Vascular Surgery | $37,500.00 |
| Steven Dean | Columbus, OH | Cardiovascular Disease | $27,479.95 |
| Steven Elias | Englewood, NJ | Vascular Surgery | $13,493.07 |
| Manu Aggarwal | Lima, OH | Family Medicine | $12,355.60 |
| Matthew Spraker | Saint Louis, MO | Radiation Oncology | $10,752.00 |
| Robert Sollaccio | Winter Park, FL | Radiation Oncology | $10,262.14 |
Prescribed Entre Plus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.